Bicara Therapeutics BCAX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Bicara Therapeutics’s reported figures.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's invested capital?
- Bicara Therapeutics (BCAX) reported invested capital of $191.94M in Q1 2026.
- How has Bicara Therapeutics's invested capital changed year-over-year?
- Bicara Therapeutics's invested capital increased by 7725.6% year-over-year, from -$2.52M to $191.94M.
- What is the long-term trend for Bicara Therapeutics's invested capital?
- Over 2 years (2023 to 2025), Bicara Therapeutics's invested capital has grown at a -10.0% compound annual growth rate (CAGR), from -$378.55M to $306.48M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).